Home/Filings/4/0001140361-11-022491
4//SEC Filing

Lalach Harvey 4

Accession 0001140361-11-022491

CIK 0001314052other

Filed

Apr 17, 8:00 PM ET

Accepted

Apr 18, 7:22 PM ET

Size

7.5 KB

Accession

0001140361-11-022491

Insider Transaction Report

Form 4
Period: 2011-04-14
Lalach Harvey
DirectorPresident CEO CFO
Transactions
  • Sale

    common stock

    2011-04-14$2.75/sh10,000$27,500579,872 total
Holdings
  • stock options

    Exercise: $3.50From: 2010-06-29Exp: 2015-06-29common stock (50,000 underlying)
    200,000
  • common stock

    589,872
  • stock options

    Exercise: $3.10From: 2008-06-03Exp: 2013-06-03common stock (150,000 underlying)
    150,000

Documents

1 file

Issuer

ANAVEX LIFE SCIENCES CORP.

CIK 0001314052

Entity typeother

Related Parties

1
  • filerCIK 0001360545

Filing Metadata

Form type
4
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 7:22 PM ET
Size
7.5 KB